The Common Equipment Core resource provides support to Cancer Center Investigators for the maintenance and operation of equipment that is shared among multiple groups or programs with an emphasis to ensure young investigators access to equipment necessary to their laboratories. The services provided by this resource are repair and/or preventative maintenance contracts for shared equipment, annual inspections of freezers, cryo units and balances, water filters for film processors and ice machines and maintenance and chemicals for the film processors. Shared equipment covered are three film processors, eight ice machines, four autoclaves (1 in CRBII), two Coulter counters, two real time PCR instruments, two liquid scintillation/luminescence counters, two stills, and A/V equipment in four shared conference rooms. Equipment such as ultra centrifuges, mid-range centrifuges, scintillation counters, and imaging equipment are included to make sure young investigators have access to necessary equipment crucial in developing their laboratory programs. All equipment is currently located in the Bunting-Blaustein Building and some will be located in CRBII when it opens in January 2006. Service monitoring and oversight are provided by the Laboratory Facilities and Services Manager and the Laboratory Services Coordinator. User logs are required and kept for each piece of equipment where appropriate. Exceptions are autoclaves, film processors, ice machines and A/V equipment. There is no charge back system for these services. There is a chargeback for the use of the real time PCR units, the liquid scintillation/luminescence counters (as of January 2005) and cryo storage.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-46
Application #
7726516
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
46
Fiscal Year
2008
Total Cost
$54,972
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ye, I Chae; Fertig, Elana J; DiGiacomo, Josh W et al. (2018) Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes. Mol Cancer Res 16:1889-1901
Kaur, Harsimar B; Guedes, Liana B; Lu, Jiayun et al. (2018) Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer. Mod Pathol 31:1539-1552
Connolly, Roisin M; Fackler, Mary Jo; Zhang, Zhe et al. (2018) Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Res Treat 167:107-116
Rao, Karthik; Liang, Stella; Cardamone, Michael et al. (2018) Cost implications of PSA screening differ by age. BMC Urol 18:38
Zhu, Yezi; Sharp, Adam; Anderson, Courtney M et al. (2018) Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer. Eur Urol 73:727-735
Lu, Yunqi; Hu, Zhongyi; Mangala, Lingegowda S et al. (2018) MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. Cancer Res 78:64-74
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Johnson, Renee M; Fleming, Charles B; Cambron, Christopher et al. (2018) Race/Ethnicity Differences in Trends of Marijuana, Cigarette, and Alcohol Use Among 8th, 10th, and 12th Graders in Washington State, 2004-2016. Prev Sci :
Marrone, Kristen A; Zhou, Xian; Forde, Patrick M et al. (2018) A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. Oncologist 23:859-865
Bar-Shir, Amnon; Alon, Lina; Korrer, Michael J et al. (2018) Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy. Magn Reson Med 79:1010-1019

Showing the most recent 10 out of 2393 publications